DoMore Diagnostics
Personalised cancer treatment delivered with AI
DoMore Diagnostics develops AI-powered digital biomarkers for precision oncology. The company aims to personalise cancer treatment and reduce over- and undertreatment.
| Best for | clinicians seeking AI-driven diagnostic support |
| Website | domorediagnostics.com |
Strengths and trade-offs
- The AI tool predicts survival outcomes in colorectal cancer patients.
- DoMore Diagnostics has secured up to €10 million in EIC funding.
Appears in
Alternatives to DoMore Diagnostics
 MindpeakDecoding tissue for the future of medicine | #1 in Best AI pathology tools | 84.0 |
 Indica LabsAI-Powered Pathology from discovery to diagnostics | #2 in Best AI pathology tools | 80.0 |
 LunitPartnering to advance cancer detection and precision oncology | #3 in Best AI pathology tools | 80.0 |
 VisiopharmAI-driven precision pathology software for research and diagnostics | #4 in Best AI pathology tools | 80.0 |
 ProsciaPathology AI for precision medicine | #5 in Best AI pathology tools | 78.0 |
 AiforiaTranslate images into discoveries, decisions, and diagnoses | #7 in Best AI pathology tools | 74.0 |
Questions about DoMore Diagnostics
Who is DoMore Diagnostics best for?
DoMore Diagnostics is best for clinicians seeking AI-driven diagnostic support.
Where does DoMore Diagnostics rank?
DoMore Diagnostics is ranked #6 in Best AI pathology tools (Lister Score 76.0).
What are the best alternatives to DoMore Diagnostics?
The closest alternatives on Lister are Mindpeak (#1 in Best AI pathology tools), Indica Labs (#2 in Best AI pathology tools) and Lunit (#3 in Best AI pathology tools).
Is this your company?
Claim DoMore Diagnostics to suggest corrections to its listing (pricing, features, details) or ask about an enhanced profile. We review every claim before anything changes.